Related compounds & supplies
5-amino-1MQ
What is it?
5-amino-1MQ refers to 5-amino-1-methylquinolinium, a small molecule investigated as an inhibitor of nicotinamide N-methyltransferase (NNMT). It is not a peptide, despite appearing in peptide supplier catalogues. The counterion and exact chemical form matter when defining the material.
How it is studied
NNMT is involved in nicotinamide metabolism. Experimental inhibition explores links between methylation, NAD-related metabolism and adipose-tissue biology. Enzyme inhibition is a mechanistic finding, not evidence of a safe or effective weight-loss product for people.
What the evidence shows
A 2018 study examined selective NNMT inhibitors in cell systems and diet-induced obese mice. Further 2024 work investigated body composition, metabolic variables and tissue distribution in mice. These are preclinical studies and do not establish human treatment outcomes.
Limitations & safety context
Mouse effects cannot determine a human regimen, long-term safety or guaranteed fat loss. Chemical identity, counterion and impurity profiles must be verified before matching a vial to a publication. The attachment’s listed mass does not resolve these questions.
Listed specifications
| Reference | Listed contents |
|---|---|
| 5AM | 5 mg |
| 50AM | 50 mg |
Source-document quantities, not doses or a confirmation of stock. Identity, purity, component composition and suitability require separate documentation.
Research information only. No dosing, administration or treatment advice.